HEALTH CARE–ASSOCIATED INFECTIONS: INTRODUCTION
The costs of hospital-acquired (nosocomial) and other health care–associated infections are great. It is estimated that these infections affect >2 million patients, cost $4.5 billion, and contribute to 88,000 deaths in U.S. hospitals annually. Efforts to lower infection risks have been challenged by the growing numbers of immunocompromised patients, antibiotic-resistant bacteria, fungal and viral superinfections, and invasive devices and procedures. Nevertheless, evidence-based guidelines for prevention and control are available (Table 125-1); according to some estimates, consistent application of these guidelines may reduce the risk of health care–associated infection by more than one-third, and the growing viewpoint of consumer advocates is that almost all such infections are preventable. This chapter reviews health care–acquired and device-related infections and the basic surveillance, prevention, control, and treatment activities that have been developed to deal with these problems.
Table 125-1 Sources of Infection-Control Guidance and Oversight
The excerpt above is an example of the information available at Harrison's Practice.
For full access, please subscribe today!

Subscribers, log into your account below. |
| About Harrison's Practice Harrison's Practice delivers practical, concise answers to your clinical questions in an innovative and easy-to-navigate format. Available anytime, anywhere on Web, Web Wireless, and PDA, all for one subscription rate! To see a complete, unabridged topic click on any of the Free Topics below: Learn more |